Barcelona, 27 mar (.).- La farmacéutica Almirall ha logrado un préstamo del Banco Europeo de Inversiones (BEI) de 120 millones de euros para financiar su esfuerzos en investigación y desarrollo (I+D).

En una comunicación a la CNMV, el supervisor bursátil, la farmacéutica controlada por los hermanos Gallardo ha dado a conocer este miércoles la firma de este préstamo con el BEI.

La compañía ha precisado que el primer tramo, de 80 millones, tiene un interés fijo al 1,35 % durante diez años, y que los fondos del BEI se usarán para «ofrecer innovación de vanguardia y terapias diferenciadas en el área de dermatología médica».

Aviso legal: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.